PharmiWeb.com - Global Pharma News & Resources

Biotech - Press Releases

Date Title Company
04-Sep-2024 Phesi wins Frost & Sullivan’s Global Enabling Technology Leadership Award for Revolutionizing Clinical Development with its Trial Accelerator Platform Phesi
04-Sep-2024 Kosten Digital Launches in the U.S. to Transform Life Sciences with Custom AI Solutions, Welcomes Industry Leader Amy DuRoss to Advisory Board Kosten Digital
04-Sep-2024 Russell Abberley, Amgen UK & Ireland, steps up as Acting ABPI President Association of the British Pharmaceutical Industry (ABPI)
04-Sep-2024 Envirotainer completes integration of va-Q-tec’s pharma business, advancing the future of pharma cold chain Envirotainer
04-Sep-2024 Vesper Bio announces successful Phase I study for potentially disease-modifying treatment for frontotemporal dementia Vesper Bio
04-Sep-2024 PulseSight Therapeutics reinforces its scientific leadership in ophthalmology with the establishment of an International Scientific and Clinical Advisory Board PulseSight Therapeutics SAS
04-Sep-2024 Aixial Group Migrates Specific Clinical Data Portfolio Onto Medidata Platform to Create a Single Source of Truth and Accelerate Database Lock Medidata
04-Sep-2024 Prilenia’s Pridopidine for Huntington’s Disease Accepted for European Marketing Authorisation Review Prilenia Therapeutics B.V
04-Sep-2024 NH TherAguix announces continuation of the Phase II NANOBRAINMETS trial in the treatment of brain metastases after completion of a futility analysis NH TherAguix (NHT)
04-Sep-2024 GenesisCare UK appoints Second Doctor Director to UK Board GenesisCare UK
04-Sep-2024 QL Biopharm Announces Abstract on Novel Ultra Long-acting GLP-1RA to be Presented at EASD Annual Meeting 2024 QL Biopharm
04-Sep-2024 SeaBeLife receives Orphan Drug Designation (ODD) from EMA for treatment of acute liver failure SeaBeLife
04-Sep-2024 FDB Recognized as a Top Workplace in San Francisco Bay Area FDB
04-Sep-2024 Lindus Health Launches "All-in-One Ophthalmology CRO" Tailored to Clinical Trials in Ophthalmology Lindus Health
03-Sep-2024 SeaBeLife receives Orphan Drug Designation (ODD) from EMA for treatment of acute liver failure Andrew Lloyd Associates
02-Sep-2024 Theolytics Awarded Significant £2M Transforming Cancer Therapeutics Grant from Innovate UK Theolytics
02-Sep-2024 Nxera Pharma to Receive US$35 Million from Neurocrine Biosciences upon Positive Phase 2 Data for Partnered Schizophrenia Candidate NBI-1117568 Neurocrine Biosciences
02-Sep-2024 Medigene AG Secures Two Additional Patents for Technologies in Its End-to-End Platform Medigene AG
02-Sep-2024 ACG Inspection awarded GS1 Nigeria Gold Partnership ACG Inspection
02-Sep-2024 New Service Center in Veeva Vault CRM Suite Unifies Sales and Service Veeva Systems